ArticlePDF Available

First report of autochthonous transmission of Zika virus in Brazil

Authors:
  • Instituto Carlos Chagas/Fiocruz - PR
  • Instituto Carlos Chagas - Fiocruz/PR

Abstract and Figures

In the early 2015, several cases of patients presenting symptoms of mild fever, rash, conjunctivitis and arthralgia were reported in the northeastern Brazil. Although all patients lived in a dengue endemic area, molecular and serological diagnosis for dengue resulted negative. Chikungunya virus infection was also discarded. Subsequently, Zika virus (ZIKV) was detected by reverse transcription-polymerase chain reaction from the sera of eight patients and the result was confirmed by DNA sequencing. Phylogenetic analysis suggests that the ZIKV identified belongs to the Asian clade. This is the first report of ZIKV infection in Brazil.
Content may be subject to copyright.
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 110(4): 569-572, June 2015 569
online | memorias.ioc.fiocruz.br
First report of autochthonous transmission of Zika virus in Brazil
Camila Zanluca
1
, Vanessa Campos Andrade de Melo
2
, Ana Luiza Pamplona Mosimann
1
,
Glauco Igor Viana dos Santos
2
, Claudia Nunes Duarte dos Santos
1
/
+
, Kleber Luz
3
/
+
1
Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, PR, Brasil
2
Secretaria Estadual de Saúde do Rio Grande do Norte, Natal, RN, Brasil
3
Instituto de Medicina Tropical, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
In the early 2015, several cases of patients presenting symptoms of mild fever, rash, conjunctivitis and arthral-
gia were reported in the northeastern Brazil. Although all patients lived in a dengue endemic area, molecular and
serological diagnosis for dengue resulted negative. Chikungunya virus infection was also discarded. Subsequently,
Zika virus (ZIKV) was detected by reverse transcription-polymerase chain reaction from the sera of eight patients
and the result was confirmed by DNA sequencing. Phylogenetic analysis suggests that the ZIKV identified belongs
to the Asian clade. This is the first report of ZIKV infection in Brazil.
Key words: Zika virus - “dengue-like syndrome” - Brazil
doi: 10.1590/0074-02760150192
Financial support: FIOCRUZ, CNPq, CAPES, Fundação Araucária
+ Corresponding authors: clsantos@fiocruz.br, klebergluz@gmail.com
Received 17 May 2015
Accepted 25 May 2015
Zika virus (ZIKV) is an emerging arthropod borne
virus (arbovirus) transmitted by Aedes (Stegomyia)
mosquitoes. The virus belongs to the genus Flavivirus,
family Flaviviridae, and is closely related to other fla-
viviruses of public health relevance including dengue
(DENV), yellow fever and West Nile viruses (Pierson &
Diamond 2013, Faye et al. 2014).
ZIKV was first isolated from a rhesus monkey in the
Zika Forest of Uganda, in 1947 (Dick et al. 1952). For
half a century, the virus was described as causing spo-
radic human infections in Africa and Asia, until 2007
when a Zika fever epidemics took place in Yap Island,
Micronesia (Duffy et al. 2009). In 2013, a large epidemic
was reported in French Polynesia, concomitant with a
dengue epidemic caused by serotypes 1 and 3. ZIKV has
been considered as emergent since 2007 (Cao-Lormeau
et al. 2014, Ioos et al. 2014).
In the early 2015, records of patients presenting a
dengue-like syndrome” appeared in the public health
service in the city of Natal (05°47’42”S 35°12’32”O), state
of Rio Grande do Norte, Brazil. A physician specialist in
infectious disease evaluated the patients and the clinical
signs and symptoms and laboratory findings indicated
a non-DENV and non-Chikungunya virus (CHIKV) in-
fection. Symptoms included arthralgia, oedema of ex-
tremities, mild fever, maculopapular rashes frequently
pruritic, headaches, retroorbital pain, no purulent con-
junctivitis, vertigo, myalgia and digestive disorder.
By March 2015, the Molecular Virology Laborato-
ry of Carlos Chagas Institute, Oswaldo Cruz Institute,
state of Para, Brazil, received 21 acute-phase serum
specimens from those patients exhibiting the “dengue-
like syndrome”. Sera were transported and kept at -80ºC
until use. The protocol was approved by the Brazilian
Ethical Committee (42481115.7.0000.5248).
After RNA extraction, reverse transcription-polymer-
ase chain reaction (RT-PCR) was performed as a rapid
molecular tool to detect viral infection in acute-phase
samples. Viral RNA was extracted from 140 µL of sera
by using QIAamp viral RNA mini kit (Qiagen, USA) ac-
cording to the manufacturer’s instructions.
The sera were first tested for DENV by RT-PCR
(Lanciotti et al. 1992), ELISA for non-structural protein
1 antigen detection (Dengue Early ELISA, PanBio) and
anti-DENV IgM (Dengue IgM Capture ELISA, PanBio),
all yielded negative results. Moreover, all samples ren-
dered negative results in RT-PCR assays for CHIKV in-
fection (Lanciotti et al. 2007).
Since clinical symptoms were compatible with ZIKV
infection, RT-PCR assay to specifically detect ZIKV RNA
was performed, as described by Faye et al. (2008), with the
modification that, instead of a one step, a two step protocol
was used (cDNA synthesis followed by the PCR).
Amplicons of 364 bp encompassing the envelope
protein coding region were obtained for eight out of 21
samples (Fig. 1). Two of the resultant amplicons were
purified with High Pure PCR Purification kit (Roche)
and sequenced in an ABI 3500 Genetic Analyzer (Ap-
plied Biosystems). Sequences were assembled using
the Assembler tool (hpa-bioinformatics.org.uk/cgi-bin/
assembly_tool/seq_assemble.cgi?no=2) (GenBank ac-
cessions KR815989 and KR815990) and their identity
were confirmed by Basic Local Alignment Search Tool
(BLAST) and compared to other ZIKV sequences. Re-
sults demonstrated a high identity with sequences from
the ZIKV Asian lineage. Despite the similarity of the
clinical findings, the remaining samples resulted nega-
tive in RT-PCR, probably due to the short (and low) vi-
raemia period (between the 3rd and 5th day after the
onset of clinical symptoms).
ZIKV transmission in Brazil • Camila Zanluca et al.
570
Phylogenetic analysis of the sequences (Fig. 2) placed
the Brazilian strains in a clade with sequences from the
Asian lineage. The highest identity scores in BLAST
were observed with the H/PF/2013 (99%, GenBank ac-
cession KJ776791), CK-ISL 2014 (99%, GenBank acces-
sion KJ634273) and FSS13025 (99%, GenBank acces-
sion JN860885) isolates. The two generated sequences
were identical between themselves in the region that was
analysed (Fig. 2) and was identified as 15095_BR_2015.
These results corroborate previously published data
about the spread of the ZIKV Asian lineage that was first
reported in the outbreaks of the Pacific Islands (Musso
et al. 2014). To track the introduction of ZIKV in Brazil
a retrospective and more extensive analysis of additional
Fig. 1: agarose gel electrophoresis of reverse transcription-polymerase chain reaction assays for Zika virus (ZIKV) detection. The arrow indicates
the 364 bp amplicon expected for ZIKV. RNA extracted from serum samples of patients in acute-phase of dengue fever and Chikungunya fever
and a negative serum sample were included as negative controls. CHIKV: Chikungunya virus; M: molecular size marker; 1-21: serum samples.
Fig. 2: phylogenetic analysis based on partial E gene nucleic acid sequence (nt 1655-1984 according to AY632535) of a 2015 Brazilian strain of
Zika virus. The tree was inferred using the maximum likelihood algorithm based on the Kimura two-parameter model with invariant sites as
implemented in MEGA 6.05. The numbers shown to the left of the nodes represent bootstrap support values > 70 (1,000 replicates). The tree
was rooted with Spondoweni virus and branch lengths do not represent genetic distance. Strains were labelled according to GenBank accession
/country 2-letter acronym/year of isolation.
571
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 110(4), June 2015
samples from other Brazilian regions is needed, as well
as a complete viral genetic characterisation. However,
one plausible hypothesis is the arrival of the new emer-
gent virus during the soccer World Cup in 2014.
Seven of the eight patients with confirmed ZIKV dis-
ease were female, the median age was 39 years (range, 18-
65), all of them lived in Natal and had relatives with the
same symptoms. The most commonly reported symptoms
were maculopapular rash (100%) (Fig. 3) and pain. The
pain scale was applied for six of them and the pain levels
were high in most patients, with levels of zero (1/7), seven
(2/7), nine (1/7) or 10 (2/7). The pain duration ranged from
two-15 days, except for one patient who had pain for more
than 21 days. Other symptoms included headache (6/8),
retroorbital pain (4/8) and myalgia (6/8). Myalgia was not
intense. Joint pain was reported for seven patients, includ-
ing pain in the hands (5), ankle (4), elbow (4), knee and
wrist (3) and foot (2); one patient reported cervical pain.
During the clinical examination, all the patients were
haemodynamically normal and periarticular swelling
(Fig. 3) was present in six of them, with predominance
in the hands (50%). Fever was reported in six patients,
but high fever (around 39ºC) in only two. The duration
of fever ranged from one-eight days. Submandibular or
cervical lymphadenopathy (Fig. 3) occurred in three pa-
tients. No purulent conjunctivitis was observed. ZIKV
can produce a clinical relevant disease, which lasts for
approximately two weeks. The patients observed in Na-
tal had intense pain resembling CHIKV infection, but
the clinical course was shorter. To date, no death or com-
plications were associated with ZIKV illness in Natal.
The blood cell count revealed that only two patients had
leukopaenia, the others had normal levels of leukocytes and
neutrophils and platelets were normal in all of them. The
tourniquet tests were negative in seven of the patients.
We report here the first identification of ZIKV as the
causative agent of an outbreak in the northeastern Bra-
zil. It represents the first autochthonous transmission of
ZIKV in the country. Although most of the patients had
mild illness, clinicians and public health officials should
be aware of the risk of expansion of this new emerging
virus, especially given the naïve immunological status
of the Brazilian population. Spreading of the disease in
the country might occur by virtue of the large population
mobility and the widespread occurrence of the transmit-
Fig. 3: Zika virus clinical findings in patients from Natal, state of Rio Grande do Norte, Brazil. A: lymphadenopathy; B: maculopapular rash;
C: periarticular swelling.
ting vectors. Furthermore the complex epidemiological
context with the co-circulation of DENV, CHIKV and
ZIKV cannot be neglected. DENV and ZIKV (Dupont-
Rouzeyrol et al. 2015) or DENV and CHIKV (Caron et
al. 2012) co-infections have already been reported.
The effect of the concurrent outbreaks caused by
these three different arboviruses is unknown. ZIKV dis-
ease was associated with neurological and autoimmune
complications in a context of concurrent circulation with
DENV in French Polynesia (Roth et al. 2014). DENV also
circulates in Natal. Further studies are needed to unveil
whether co-infection and subsequent infection by differ-
ent arboviruses can affect the course of the disease, the
occurrence of severe cases and the ways of transmission
(vertical, perinatal, sexual) (Foy et al. 2011, Besnard et
al. 2014, Musso et al. 2015). Of interest, recent paper by
Gourinat et al. (2015) shows evidence of virus secretion
in urine for more than 10 days after onset of disease.
The correct clinical and laboratorial differential di-
agnosis between acute ZIKV, CHIKV and DENV in-
fection will contribute to the patientsprognosis and to
drive surveillance actions.
ACKNOWLEDGEMENTS
To the Sequencing Platform of the Department of Biochem-
istry and Molecular Biology of the Federal University of Paraná,
for viral genomic sequencing, to Dr Helisson Faoro, for discus-
sion, and to Dra Andreia Suzukawa, for technical assistance.
REFERENCES
Besnard M, Lasre S, Teissier A, Cao-Lormeau VM, Musso D 2014.
Evidence of perinatal transmission of Zika virus, French Polyne-
sia, December 2013 and February 2014. Euro Surveill 19: 20751.
Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet
HP, Sall AA, Musso D 2014. Zika virus, French Polynesia, South
Pacific, 2013. Emerg Infect Dis 20: 1084-1086.
Caron M, Paupy C, Grard G, Becquart P, Mombo I, Nso BB, Kassa
Kassa F, Nkoghe D, Leroy EM 2012. Recent introduction and
rapid dissemination of Chikungunya virus and dengue virus se-
rotype 2 associated with human and mosquito co-infections in
Gabon, Central Africa. Clin Infect Dis 55: e45-53.
Dick GWA, Kitchen SF, Haddow AJ 1952. Zika virus. I. Isolations and
serological specificity. Trans R Soc Trop Med Hyg 46: 509-520.
Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS,
Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs
A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ,
ZIKV transmission in Brazil • Camila Zanluca et al.
572
Fischer M, Hayes EB 2009. Zika virus outbreak on Yap Island, Fed-
erated States of Micronesia. N Engl J Med 360: 2536-2543.
Dupont-Rouzeyrol M, O’Connor O, Calvez E, Daures M, John M, Grang-
eon JP, Gourinat AC 2015. Co-infection with Zika and dengue viruses
in 2 patients, New Caledonia, 2014. Emerg Infect Dis 21: 381-382.
Faye O, Faye O, Dupressoir A, Weidmann M, Ndiaye M, Sall AA
2008. One-step RT-PCR for detection of Zika virus. J Clin Virol
43: 96-101.
Faye O, Freire CC, Iamarino A, Faye O, Oliveira JVC, Diallo M, Zan-
otto PMA, Sall AA 2014. Molecular evolution of Zika virus during
its emergence in the 20th century. PLOS Negl Trop Dis 8: e2636.
Foy BD, Kobylinski KC, Foy JLC, Blitvich BJ, da Rosa AT, Haddow AD,
Lanciotti RS, Tesh RB 2011. Probable non-vector-borne transmis-
sion of Zika virus, Colorado, USA. Emerg Infect Dis 14: 880-882.
Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol
M 2015. Detection of Zika virus in urine. Emerg Infect Dis 21:
84-86.
Ioos S, Mallet HP, Goffart IL, Gauthier V, Cardoso T, Herida M 2014.
Current Zika virus epidemiology and recent epidemics. Med Mal
Infect 44: 302-307.
Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam V 1992.
Rapid detection and typing of dengue viruses from clinical sam-
ples by using reverse transcriptase-polymerase chain reaction. J
Clin Microbiol 30: 545-551.
Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ,
Campbell GL 2007. Chikungunya virus in US travelers returning
from India, 2006. Emerg Infect Dis 13: 764-767.
Musso D, Nilles EJ, Cao-Lor meau VM 2014. Rapid spread of emerging
Zika virus in the Pacific area. Clin Microbiol Infect 20: 595-596.
Musso D, Roche C, Robin E, Nhan T, Teisser A, Cao-Lormeau VM
2015. Potential sexual transmission of Zika virus. Emerg Infect
Dis 21: 359-361.
Pierson TC, Diamond MS 2013. Flaviviruses. In DM Knipe, PM
Howley (eds.), Fields virology, 6th ed., Lippincott Williams &
Wilkins, Philadelphia, p. 747-794.
Roth A, Mercier A, Lepers C, Hoy D, Duituturaga S, Benyon E, Guil-
laumot L, Souares Y 2014. Concurrent outbreaks of dengue, Chi-
kungunya and Zika virus infections - an unprecedented epidemic
wave of mosquito-borne viruses in the Pacific 2012-2014. Euro
Surveill 19: 20929.
... ZIKV was first isolated in 1947 from a rhesus monkey in the Zika forest in Uganda [12], and for six decades since its discovery, the virus remained confined to Africa and Asia, causing only sporadic outbreaks [13]. During large-scale outbreaks in the Pacific Region starting in 2007 [14] and the Americas starting in 2015 [15], ZIKV has shown its potential for a rapid population spread as well as its association with severe neurological complications in fetuses, neonates, and adults [16,17]. The teratogenic potential identified was an unprecedented feature in a mosquito-borne viral infection with dramatic implications for affected communities [18]. ...
Article
Full-text available
Arboviral diseases are serious threats to global health with increasing prevalence and potentially severe complications. Significant arthropod-borne viruses are the dengue viruses (DENV 1-4), the Zika virus (ZIKV), and the chikungunya virus (CHIKV). Among the areas most affected is the South Pacific Region (SPR). Here, arboviruses not only cause a high local burden of disease, but the region has also proven to contribute to their global spread. Outpatient serum samples collected between 08/2016 and 04/2017 on three islands of the island states of Vanuatu and the Cook Islands were tested for anti-DENV-and anti-ZIKV-specific antibodies (IgG) using enzyme-linked immuno-sorbent assays (ELISA). ELISA test results showed 89% of all test sera from the Cook Islands and 85% of the Vanuatu samples to be positive for anti-DENV-specific antibodies. Anti-ZIKV antibodies were identified in 66% and 52%, respectively, of the test populations. Statistically significant differences in standardized immunity levels were found only at the intranational level. Our results show that in both the Cook Islands and Vanuatu, residents were exposed to significant Flavivirus transmission. Compared to other seroprevalence studies, the marked difference between ZIKV immunity levels and previously published CHIKV seroprevalence rates in our study populations is surprising. We propose the timing of ZIKV and CHIKV emergence in relation to recurrent DENV outbreaks and the impact of seasonality as explanatory external factors for this observation. Our data add to the knowledge of arboviral epidemics in the SPR and contribute to a better understanding of virus spread, including external conditions with potential influence on outbreak dynamics. These data may support preventive and rapid response measures in the affected areas, travel-related risk assessment , and infection identification in locals and returning travelers.
... In February 2016, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) in response to an increasing ZIKV outbreak in Latin America [10][11][12]. Although the link between ZIKV infection and newly reported clusters of microcephaly and other neurological disorders was unclear [13], the WHO called for increased Zika surveillance and research related to ZIKV, microcephaly, and other neurological disorders worldwide. ...
Article
Background In response to the 2015–2016 Zika virus (ZIKV) outbreak and the causal relationship established between maternal ZIKV infection and adverse infant outcomes, we conducted a cohort study to estimate the incidence of ZIKV infection in pregnancy and assess its impacts in women and infants. Methodology/Principal findings From May 2018-January 2020, we prospectively followed pregnant women recruited from 134 participating hospitals in two non-adjacent provinces in northeastern Thailand. We collected demographic, clinical, and epidemiologic data and blood and urine at routine antenatal care visits until delivery. ZIKV infections were confirmed by real-time reverse transcriptase polymerase chain reaction (rRT-PCR). Specimens with confirmed ZIKV underwent whole genome sequencing. Among 3,312 women enrolled, 12 (0.36%) had ZIKV infections, of which two (17%) were detected at enrollment. Ten (83%, 3 in 2 nd and 7 in 3 rd trimester) ZIKV infections were detected during study follow-up, resulting in an infection rate of 0.15 per 1,000 person-weeks (95% CI: 0.07–0.28). The majority (11/12, 91.7%) of infections occurred in one province. Persistent ZIKV viremia (42 days) was found in only one woman. Six women with confirmed ZIKV infections were asymptomatic until delivery. Sequencing of 8 ZIKV isolates revealed all were of Asian lineage. All 12 ZIKV infected women gave birth to live, full-term infants; the only observed adverse birth outcome was low birth weight in one (8%) infant. Pregnancies in 3,300 ZIKV-rRT-PCR-negative women were complicated by 101 (3%) fetal deaths, of which 67 (66%) had miscarriages and 34 (34%) had stillbirths. There were no differences between adverse fetal or birth outcomes of live infants born to ZIKV-rRT-PCR-positive mothers compared to live infants born to ZIKV-rRT-PCR-negative mothers. Conclusions/Significance Confirmed ZIKV infections occurred infrequently in this large pregnancy cohort and observed adverse maternal and birth outcomes did not differ between mothers with and without confirmed infections.
... The Zika (ZIKV) and chikungunya (CHIKV) viruses are RNA arboviruses from the Flaviviridae and Togaviridae families, respectively, which have quickly spread in recent years to various parts of the world, including Brazil [10][11][12]. These pathogens are a major public health concern, as they cause infections in humans that can trigger neurological complications, such as the Guillain-Barré Syndrome [13] and the Congenital Zika Syndrome [14], as well as cardiac manifestations [15] and painful and disabling polyarthralgia [16]. ...
Article
Full-text available
Zika (ZIKV) and chikungunya (CHIKV) are arboviruses that cause infections in humans and can cause clinical complications, representing a worldwide public health problem. Aedes aegypti is the primary vector of these pathogens and Culex quinquefasciatus may be a potential ZIKV vector. This study aimed to evaluate fecundity, fertility, survival, longevity, and blood feeding activity in Ae. aegypti after exposure to ZIKV and CHIKV and, in Cx. quinquefasciatus exposed to ZIKV. Three colonies were evaluated: AeCamp (Ae. aegypti—field), RecL (Ae. aegypti—laboratory) and CqSLab (Cx. quinquefasciatus—laboratory). Seven to 10 days-old females from these colonies were exposed to artificial blood feeding with CHIKV or ZIKV. CHIKV caused reduction in fecundity and fertility in AeCamp and reduction in survival and fertility in RecL. ZIKV impacted survival in RecL, fertility in AeCamp and, fecundity and fertility in CqSLab. Both viruses had no effect on blood feeding activity. These results show that CHIKV produces a higher biological cost in Ae. aegypti, compared to ZIKV, and ZIKV differently alters the biological performance in colonies of Ae. aegypti and Cx. quinquefasciatus. These results provide a better understanding over the processes of virus-vector interaction and can shed light on the complexity of arbovirus transmission.
... These arboviruses are of concern because of their epidemic background in Brazil (Ministério da Saúde, 2020bWHO, 2022). A. aegypti also transmits the viruses that cause chikungunya (CHIKV) and Zika (ZIKV), which have caused public health concern in the country since 2014 (Nunes et al., 2015;Zanluca et al., 2015;Ministério da Saúde, 2019;WHO, 2022). ...
Article
Full-text available
Brazil has been suffering a dengue (DENV) epidemic in 2019 and 2022 and records cases of Zika (ZIKV) and chikungunya (CHIKV). Londrina city, Paraná, stands out for the number of cases and deaths from dengue. Therefore, this study aimed to verify the density and diversity of mosquitoes present in urban public establishments of Londrina, to analyze their ecological relationships, and to investigate the presence of the DENV, ZIKV, and CHIKV. Ovitraps were installed in outdoor sites in two public establishments in each region of Londrina, while adult culicids were caught indoors with a Nasci aspirator. A total of 5077 eggs were obtained in 77 ovitraps. The South region had the highest infestation while the East had the lowest (Ovitrap Positivity Index: 38% and 25%; Egg Density Index: 67.83 and 19.03, respectively). From eggs, 704 Aedes aegypti females and 71 Aedes albopictus females were obtained, while in the aspiration of adults, 99 A. aegypti and 11 Culex quinquefasciatus were captured, the highest number in the West and the lowest in the North. The DENV-II virus was detected in a pool of 17 A. aegypti females in the West region. The results demonstrate high density of pathogen vector species, mainly A. aegypti, in and around establishments, alerting to the need for constant local entomological surveillance to prevent viral circulation, mainly in crowded places. The presence of A. albopictus around the establishments also alerts to the urbanization of the species and potential participation in the viral circulation, demonstrating the need for constant monitoring. Keywords: Mosquitoes; Urbanization; Ecology; Viral investigation
... Subsequently, in 2014, another significant outbreak occurred in French Polynesia [7]. At the end of 2015, the virus was detected for the first time in Brazil [8]; since then, it has attracted global attention due to its rapid expansion, particularly in tropical and subtropical regions. As of January 2018, the Centers for Disease Control and Prevention (CDC) had reported 223,477 confirmed cases in 87 countries and territories worldwide, of which 48 are from Latin America [9,10]. ...
Article
Full-text available
Zika virus (ZIKV) is an emerging flavivirus that represents significant public health challenges, particularly in the Americas, and is a substantial risk to other parts of the world due to its rapid expansion and its established association with neurological disorders, including Guillain–Barré syndrome and an intrauterine fetal infection that can cause microcephaly, blindness, and other congenital neurological complications. To date, no vaccine to prevent ZIKV infections has been approved. Therefore, developing a safe and effective vaccine against this virus is a global health priority. This review analyzes the ZIKV outbreaks, as well as associated neurological complications, its genome, and immunological responses. The current vaccines in development have reported results from preclinical and clinical trials about novel approaches to obtain safer and more effective vaccines and the challenges faced by ZIKV vaccine development.
... Zika (ZIKV) was originally reported in a primate in Uganda in 1947 4 . Large outbreaks were recorded in 2007 in the Pacific Islands 5 , and in the Americas a few years later 6 . The outcomes of ZIKV infection are linked with adverse fetal outcomes such as microcephaly in newborns and Guillain-Barré syndrome, which led the World Health Organization to declare global public health emergency 5 . ...
Article
Full-text available
In the last decades, dengue has become one of the most widespread mosquito-borne arboviruses in the world, with an increasing incidence in tropical and temperate regions. The mosquito Aedes aegypti is the dengue primary vector and is more abundant in highly urbanized areas. Traditional vector control methods have showing limited efficacy in sustaining mosquito population at low levels to prevent dengue virus outbreaks. Considering disease transmission is not evenly distributed in the territory, one perspective to enhance vector control efficacy relies on identifying the areas that concentrate arbovirus transmission within an endemic city, i.e., the hotspots. Herein, we used a 13-month timescale during the SARS-Cov-2 pandemic and its forced reduction in human mobility and social isolation to investigate the spatiotemporal association between dengue transmission in children and entomological indexes based on adult Ae. aegypti trapping. Dengue cases and the indexes Trap Positive Index (TPI) and Adult Density Index (ADI) varied seasonally, as expected: more than 51% of cases were notified on the first 2 months of the study, and higher infestation was observed in warmer months. The Moran's Eigenvector Maps (MEM) and Generalized Linear Models (GLM) revealed a strong large-scale spatial structuring in the positive dengue cases, with an unexpected negative correlation between dengue transmission and ADI. Overall, the global model and the purely spatial model presented a better fit to data. Our results show high spatial structure and low correlation between entomological and epidemiological data in Foz do Iguaçu dengue transmission dynamics, suggesting the role of human mobility might be overestimated and that other factors not evaluated herein could be playing a significant role in governing dengue transmission.
Chapter
Zika virus (ZIKV) was first isolated in 1947 from a rhesus macaque held captive in the Zika forest in Uganda as a sentinel for yellow fever virus circulation. The first suggestion of its potential to cause sporadic human disease dates from the early sixties in the same country, but it was not until 2007 with the outbreak in Yap state (Micronesia) that ZIKV was recognized as a cause of outbreaks of mild febrile human disease. The general perception of ZIKV as a cause of benign infections transformed with the first indications of association with Guillain-Barré Syndrome (GBS) during the 2013/14 outbreak in French Polynesia. Following its rapid emergence across the Americas in 2015/16, the declaration of “clusters of microcephaly cases and other neurological disorders in areas affected by Zika virus” as a Public Health Emergency of International Concern by WHO in February 2016 further substantiated concerns about the potential severity of ZIKV infections. By 2017, it was established that although ZIKV generally causes mild or asymptomatic infections, it is a cause of GBS in adults, and congenital ZIKV infection may result in microcephaly and other congenital central nervous system (CNS) malformations, pre-term birth and miscarriage. Since the outbreak in Micronesia ZIKV has rapidly expanded its geographic distribution, and it is currently known to affect > 85 countries in Africa, Asia, the Pacific, the Americas and the Caribbean. An estimated 2 billion people live in areas of the world with environmental suitability for ZIKV circulation. Although most countries in the Americas and the Caribbean see a decline in the number of ZIKV cases, the situation in Africa remains obscure, while for Asia, increasing evidence from retro- and prospective studies points to a wide geographical circulation. The affected countries include many popular travel destinations for European citizens, and indeed many import cases of ZIKV infections in returning travellers have been reported and continue to be reported. Given the profile of ZIKV as a (re-)emerging pathogen and as aetiology of severe disease, clinicians and public health officials should remain vigilant about the risk of ZIKV infection in (returning) travellers and for ongoing local transmission. Pre-travel advice to prevent infection, especially in case of pregnancy or pregnancy wish, is necessary. To maintain this awareness to prevent, identify, manage and investigate ZIKV cases, this chapter reviews ZIKV epidemiology, pathogenesis, diagnostics and treatment.
Article
Full-text available
Background In most cases, Zika virus (ZIKV) causes a self-limited acute illness in adults, characterized by mild clinical symptoms that resolve within a few days. Immune responses, both innate and adaptive, play a central role in controlling and eliminating virus-infected cells during the early stages of infection. Aim To test the hypothesis that circulating T cells exhibit phenotypic and functional activation characteristics during the viremic phase of ZIKV infection. Methods A comprehensive analysis using mass cytometry was performed on peripheral blood mononuclear cells obtained from patients with acute ZIKV infection (as confirmed by RT-PCR) and compared with that from healthy donors (HD). The frequency of IFN-γ-producing T cells in response to peptide pools covering immunogenic regions of structural and nonstructural ZIKV proteins was quantified using an ELISpot assay. Results Circulating CD4⁺ and CD8⁺ T lymphocytes from ZIKV-infected patients expressed higher levels of IFN-γ and pSTAT-5, as well as cell surface markers associated with proliferation (Ki-67), activation ((HLA-DR, CD38) or exhaustion (PD1 and CTLA-4), compared to those from HD. Activation of CD4⁺ and CD8⁺ memory T cell subsets, including Transitional Memory T Cells (TTM), Effector Memory T cells (TEM), and Effector Memory T cells Re-expressing CD45RA (TEMRA), was prominent among CD4⁺ T cell subset of ZIKV-infected patients and was associated with increased levels of IFN-γ, pSTAT-5, Ki-67, CTLA-4, and PD1, as compared to HD. Additionally, approximately 30% of ZIKV-infected patients exhibited a T cell response primarily directed against the ZIKV NS5 protein. Conclusion Circulating T lymphocytes spontaneously produce IFN-γ and express elevated levels of pSTAT-5 during the early phase of ZIKV infection whereas recognition of ZIKV antigen results in the generation of virus-specific IFN-γ-producing T cells.
Article
Full-text available
In December 2013, during a Zika virus (ZIKV) outbreak in French Polynesia, a patient in Tahiti sought treatment for hematospermia, and ZIKV was isolated from his semen. ZIKV transmission by sexual intercourse has been previously suspected. This observation supports the possibility that ZIKV could be transmitted sexually.
Article
Full-text available
We describe the kinetics of Zika virus (ZIKV) detection in serum and urine samples of 6 patients. Urine samples were positive for ZIKV >10 days after onset of disease, which was a notably longer period than for serum samples. This finding supports the conclusion that urine samples are useful for diagnosis of ZIKV infections.
Article
Full-text available
Since January 2012, the Pacific Region has experienced 28 new documented outbreaks and circulation of dengue, chikungunya and Zika virus. These mosquito- borne disease epidemics seem to become more frequent and diverse, and it is likely that this is only the early stages of a wave that will continue for several years. Improved surveillance and response measures are needed to mitigate the already heavy burden on island health systems and limit further spread to other parts of the world. © 2014, European Centre for Disease Prevention and Control (ECDC). All rights reserved.